
The European Union approved Microsoft’s US$7.5 billion acquisition of ZeniMax, the parent company of iconic video game publisher Bethesda Softworks.
The European Commission, the executive body of the EU, made the decision to clear the Microsoft-ZeniMax deal on Friday, March 5, according to an update on its merger case register. The Commission announced it found no competition concerns resulting from the takeover, reported CNBC.
Microsoft announced it would buy ZeniMax in September. It’s the biggest gaming acquisition in Microsoft’s history, eclipsing the US$2.5 billion the firm paid for Minecraft developer Mojang in 2014.
Bethesda is a household name in the video game industry, known for publishing a raft of successful game franchises including Fallout, The Elder Scrolls and Doom. Microsoft plans to push its subscription offering, Xbox Game Pass, by bringing Bethesda’s games to its extensive library of titles.
Microsoft envisions the future of gaming as an ecosystem that encompasses its Xbox consoles as well as Netflix-style subscription plans and cloud gaming. The company rolled its game streaming service xCloud to Android users in September and plans to launch it on iOS as a web app later this year.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas